Artificial Intelligence in Health Care & Evolving Cancer Trends

Source Domain: nihcm.org

Artificial Intelligence & Digital Technology

Read the latest on how artificial intelligence (AI) and other digital technologies are rolling out in health care and the strategies underway to guide safe and effective implementation.

AI & Mental Health: The Bipartisan Policy Center’s recent survey found that digital mental health tools are gaining traction among US adults – used by about 30% of US adults over 18 and nearly 50% of adults ages 18 to 44. Younger adults are more likely to use apps, chatbots, and online programs, while older adults report several barriers to using digital mental health tools, including privacy concerns, usability, and the loss of personal, relationship-based care.
AI & Pancreatic Cancer: The Mayo Clinic developed an AI model that can help specialists detect pancreatic cancer on routine abdominal CT scans up to three years before clinical diagnosis.
OpenAI & Drug Development: OpenAI announced that it is rolling out an early version of its AI model GPT-Rosalind to accelerate drug discovery and support life sciences research, initially available as a research preview to select customers. Novo Nordisk, maker of Ozempic and Wegovy, is also working with OpenAI across its operations – from research and development to manufacturing and supply chains – as it looks to keep pace with the rapidly expanding obesity drug market.
AI Scribes & Note Quality: A new study in Annals of Internal Medicine found that AI-generated clinical notes were lower in quality than those written by humans across five simulated primary care cases that included 11 AI scribe tools.
Administrative Burden & Costs: The Peterson Health Technology Institute released a report, informed by an expert workshop, examining how AI can reduce administrative burden and accelerate prior authorizations, while highlighting how increased billing intensity by providers drives up health care costs.

Resources & Initiatives